APA (7th ed.) Citation

JM, B., J, M., CG, O., KR, M., SJ, R., & VK, R. (2021). Unexpected Interruptions in the Inhaled Epoprostenol Delivery System: Incidence of Adverse Sequelae and Therapeutic Consequences in Critically Ill Patients. Critical care explorations, 3(10), e0548. https://doi.org/10.1097/CCE.0000000000000548

Chicago Style (17th ed.) Citation

JM, Block, Madhok J, Owyang CG, Merriman KR, Ruoss SJ, and Rao VK. "Unexpected Interruptions in the Inhaled Epoprostenol Delivery System: Incidence of Adverse Sequelae and Therapeutic Consequences in Critically Ill Patients." Critical Care Explorations 3, no. 10 (2021): e0548. https://doi.org/10.1097/CCE.0000000000000548.

MLA (9th ed.) Citation

JM, Block, et al. "Unexpected Interruptions in the Inhaled Epoprostenol Delivery System: Incidence of Adverse Sequelae and Therapeutic Consequences in Critically Ill Patients." Critical Care Explorations, vol. 3, no. 10, 2021, p. e0548, https://doi.org/10.1097/CCE.0000000000000548.